Baiksan is a materials maker whose core product is synthetic leather (artificial leather) made by combining polyurethane resin with nonwoven fabric. About 60% of revenue comes from upper and lining materials for global sports shoes such as Nike and Adidas, followed by automotive interior materials (about 15%), so overseas footwear consumption, brand orders and the exchange rate feed directly into results. In March 2026 it announced a corporate value-up plan, and in April and May it successively decided on treasury-stock purchases and cancellation, strengthening returns alongside a 4.4% dividend. What stands out is that it pairs profitability that far exceeds peer materials firms (ROE 13.0% and an operating margin of 10.6% versus peer ROE of 2-4%) with a low valuation (P/E 5.6x, P/B 0.73x, and a forward P/E of 5.4x this year), while much of its revenue is tied to global footwear-brand orders, so quarterly results can swing with overseas consumer conditions and the exchange rate.

At-a-glance assessment financial health · growth · profitability · valuation

Financial healthStable
  • Debt ratio, current ratio and interest burden all look healthy.
GrowthSlowing
  • Revenue rose 1.6% year over year, and the pace is slowing (3-year trend: rising).
  • Most recent quarter (Q1 2026) revenue was 3.1% lower than a year earlier.
ProfitabilityHealthy
  • ROE is 13.0% (controlling-interest basis). It is above the sector average.
  • Operating margin is 10.6%.
ValuationFairly valued

Ownership & governance As of 2025-12-31

Largest shareholder Kim Han-jun 34.84% (individual)

Controlling bloc incl. related parties 59.52%

With the controlling bloc holding 60%, control is very secure but the free float is thin.

🔎 In-depth analysis

🏢Business
  • Baiksan is a materials maker whose core product is synthetic leather (artificial leather) made by combining polyurethane (PU) resin with nonwoven fabric.
  • About 60% of revenue is upper and lining material for global-brand sports shoes such as Nike, Adidas and Reebok, followed by vehicle interior materials such as car seats and doors (about 15%) and materials for apparel and electronics cases.
  • Production is split between the domestic head office and an Indonesian production entity (P.T.
  • BAIKSAN INDONESIA); as one link in the supply chain of global footwear brands, the export share is high, and overseas footwear consumption, brand orders and the exchange rate feed directly into results.
  • Put simply, it is the company that makes the parts of a sneaker that look like leather.
📈Price & chart
  • The latest close is ₩9,860 and market capitalization is ₩197.5 billion.
  • The price sits below the 20-day line (₩10,072) and below the 60-day line (₩11,115).
  • Being under both the short- and mid-term moving averages, the trend is on the subdued side.
  • The RSI (an auxiliary gauge that scores the strength of gains versus declines over the past 14 days on a 0-100 scale) is 41.6, a neutral level.
  • The one-month change is -6.3%, the three-month change is -20.7%, and the position versus the 52-week high is -37.0%.
  • Relative strength against the KOSPI is 7 (on a 1-99 scale, converted from returns against the index over the past year with more recent performance weighted more heavily; higher means stronger than the market).
  • That places it in roughly the top 94% of all stocks by strength.
  • Over the past three months it lagged the index by 37.8%.
  • Chart reading is best done alongside trading volume and disclosure dates.
📊Key metrics
  • The P/E (how many times the price is of one year's profit) is 5.90x and the P/B (how many times the price is of book net assets) is 0.76x, so the price is low relative to earnings and assets.
  • On top of this comes a dividend yield of 4.4% (₩450 per share).
  • Profitability is strong, with ROE (how much is earned in a year on shareholders' equity) of 13.0% and an operating margin of 10.6%, clearly above the peer materials average.
  • The balance sheet is stable as well, with a debt ratio (debt relative to equity) of 71.9%, a current ratio of 177% and interest coverage of 4.7x.
  • One point to note is that the current P/E of 5.6x is on confirmed 2025 earnings (net profit ₩33.5 billion).
  • Usually, right after a year in which profit fell, even a low trailing P/E draws the doubt that the multiple will rise again once earnings recover; but for Baiksan the forward P/E recomputed on this year's expected earnings is 5.4x, actually lower.
  • In other words this is not a picture of profit falling again but of recovery and stability, and on that basis the current valuation is closer to undervalued than burdensome.
🚀Growth
  • Over five years revenue rose from ₩371.1 billion (2021) to ₩504.9 billion (2025).
  • In 2025 revenue was roughly flat at +1.6% over the prior year, while operating profit fell 30.0% (₩76.5 billion to ₩53.6 billion) and net profit 44.8% (₩60.7 billion to ₩33.5 billion), largely a step down from an unusually large 2024 in which the exchange rate and one-off tailwinds overlapped.
  • The important change comes after that.
  • In the most recent quarter (first-quarter 2026), operating profit was still depressed at ₩12.7 billion (-33.4%), but net profit was ₩12.9 billion, almost flat with the prior year (-1.5%).
  • Support from non-operating factors such as the exchange rate and financial gains means quarterly volatility remains, but it can be read as a sign that net profit is beginning to hold at the bottom.
  • That the forward valuation (forward P/E of 5.4x) is below the trailing basis (5.6x) points to profit not falling further from last year's reduced level and reviving again this year, even if not to a 2024-style peak.
  • Depending on external variables such as global footwear demand, orders and the exchange rate there will be quarterly swings, but the trend itself has entered a recovery phase after the slowdown.
📰Recent news & filings
  • This year's disclosures center on shareholder returns.
  • Alongside the March annual general meeting it presented a corporate value-up plan (a voluntary disclosure); in April it reported the results of a treasury-stock purchase and decided on a share cancellation; and in May it again decided on a treasury-stock purchase.
  • The pattern of buying back and cancelling its own shares to reduce the number of shares outstanding and lift earnings per share (EPS) is repeating.
  • Beyond these, the April and March large-holding reports flag changes in major shareholders' stakes, and the June corporate governance report is a periodic disclosure of governance status.
  • As for regular filings, the first-quarter report was filed in May and the business report in March.
  • This return stance, adding buybacks and cancellations to a 4.4% dividend, clearly shows a direction of returning earned profit to shareholders.
🧭Bottom line
  • Baiksan's strengths are distinct.
  • It pairs profitability that clearly exceeds peer materials firms (ROE 13.0%, operating margin 10.6% versus peer ROE of 2-4% at Kukdo Chemical, Ilshin Spinning and BYC) with a low valuation of P/E 5.6x and P/B 0.73x, a 4.4% dividend, and active returns through buybacks and cancellations.
  • Usually a low-P/B materials firm also has weak ROE, so there is a reason it is cheap; but Baiksan has high profitability and a low valuation coexisting, closer to a case where the discount is excessive.
  • Decisively, this year's forward P/E of 5.4x is below even the trailing basis, a setup in which earnings have entered a recovery trend but the price has not yet caught up.
  • At the same time, that much of revenue is tied to global footwear-brand orders means quarterly results swing with overseas consumer conditions and the exchange rate, a point to understand as the nature of the business.
  • In short, if footwear demand and the exchange rate hold and operating profit continues to recover, there is ample room for the low valuation, high dividend and high ROE to come to the fore together; in a phase where external orders wobble, the swing in quarterly results can grow larger.

🔎 Valuation vs peers Undervalued

Polyurethane synthetic leather is a chemical material yet is tied into the footwear and automotive consumer supply chain, so a polymer-materials firm (Kukdo Chemical) and an export-oriented textile/materials firm (Ilshin Spinning) are taken as the effective peer set.

PeerP/EP/BROE
Kukdo Chemical15.15x0.38x2.53%
Ilshin Spinning6.99x0.25x3.59%
BYC10.97x0.38x3.48%

Against the peer set, Baiksan's P/E of 6.2x is among the lowest and its P/B is low at 0.8x, and decisively its ROE of 13% overwhelms the peers (2-4%). Usually a low-P/B materials firm has weak ROE, so there is a reason it is cheap, but Baiksan has high profitability and a low valuation together, making the discount relatively excessive. That said, the current P/E of 5.90x is on confirmed 2025 (trailing) earnings, which stepped down right after a 2024 peak, so in a phase of falling earnings it can look cheaper than it really is. Given that first-quarter net profit this year was almost flat with the prior year, and that even on a forward basis reflecting the normalization of last year's earnings the P/E is still low at around 6x, the undervaluation signal prevails, with the halting of the operating-profit slowdown being the precondition for a re-valuation.

₩9,860 -3.80%
Market cap $130.9M

Price history Close · MA20 · MA60

Close MA20MA60

The latest close is ₩9,860 and the market capitalization is ₩197.5 billion. The price sits below its 20-day moving average (₩10,072) and below its 60-day moving average (₩11,115). It is under both its short- and medium-term moving averages, so the trend looks subdued. The RSI (a supplementary indicator that gauges the strength of gains versus losses over the past 14 days on a 0-100 scale) is 41.6, a neutral level. The one-month change is -6.3%, the three-month change is -20.7%, and the position relative to the 52-week high is -37.0%. Relative strength versus the KOSPI is 7 (on a 1-99 scale, converted from returns against the index over the past year with more weight on recent performance; higher means stronger than the market). It is stronger than roughly 6% of all stocks. Over the past three months it lagged the index by 37.8%. Chart interpretation is best done alongside trading volume and the dates on which disclosures occur.

Relative performance stock vs index · start = 100

7Relative strength vs KOSPI1–99 · last 12 months’ return vs the index, recency-weighted · higher = stronger than the marketTop 94% strength

Excess return vs index · 3M -37.82% / 6M -52.08% / 12M -72.97%

StockKOSPI

Key metrics vs sector median

Valuation

P/E (trailing)5.90x
Forward P/E4.89x
P/B0.76x
Forward P/B0.67x
P/S0.38x
EPS₩1,673
BPS (book value/share)₩12,912
Dividend yield4.56%
DPS₩450

The P/E of 5.90x is below the sector median (12.90x). The P/B is 0.76x.

Enterprise value (EV)

Net debt-$11.1M
EV (enterprise value)$121.2M
EV/EBIT3.41x
EV/EBITDA2.96x
EV/Sales0.36x
FCF (free cash flow)$17.5M
FCF yield13.20%

EV = market cap + net debt. It reflects cash and debt, so it captures the real cost of the whole business that market cap alone misses; lower multiples are cheaper relative to earnings or sales.

Profitability & financials

ROE12.95%
Operating margin10.62%
Net margin6.63%
Debt ratio71.94%
Payout ratio27.90%

Return on equity (ROE) is 13.0%, above the sector average (6.0%). The operating margin is 10.6%. The debt ratio is 71.9%, so the financial structure is stable.

Growth FY2025 · annual report (consolidated)

Item202320242025YoY
Revenue$276.9M$329.4M$334.6M+1.60% ↓ slower
Operating profit$35.2M$50.7M$35.5M-29.96% ↓ slower
Net profit$27.4M$40.3M$22.2M-44.84% ↓ slower
5-year20212022202320242025
Revenue$245.9M$315.4M$276.9M$329.4M$334.6M
Operating profit$15.4M$33.3M$35.2M$50.7M$35.5M
Net profit$12.7M$30.0M$27.4M$40.3M$22.2M
Revenue CAGR4-yr avg 8.00%

Revenue rose 1.6% year over year (2023 ₩417.7 billion → 2024 ₩497.0 billion → 2025 ₩504.9 billion), and the three-year trend is 'rising'. That said, the pace of growth slowed from the prior year. Operating profit fell 30.0% year over year. The decline widened. Over the 5 years on record, revenue compound annual growth (CAGR) is 8.0%. The two-year revenue CAGR is 9.9%. In the most recent quarter (Q1 2026), revenue was 3.1% lower than the same period a year earlier.

Latest quarterly results Q1 2026 · vs year-ago

Revenue$86.2M
Revenue YoY-3.06%
Operating profit$8.4M
Op. profit YoY-33.36%
Net profit$8.6M
Net profit YoY-1.46%

Technical indicators

RSI (14)41.6
MA20₩10,072
MA60₩11,115
1-month-6.27%
3-month-20.74%
vs 52-wk high-37.04%

What stands out

  • The dividend yield, at 4.6%, is on the high side.
  • ROE of 13.0% points to solid profitability.
  • The balance sheet is stable in terms of debt and liquidity.

Points to watch

  • Revenue rose 1.6% year over year, and the pace is slowing (3-year trend: rising).

Recent news & events searched · sourced

Figure cross-check computed ↔ external

MetricComputedExternalStatusSource
Trailing P/E6.16xConfirmedlink
Dividend yield / dividend per share4.37%DPS ₩450Confirmedlink
Shareholder returns (treasury stock and cancellation)DARTConfirmedlink
2026 forward net profit (internal estimate)approx. 350 (forward PER approx. 5.9x)Unverifiedlink

Recent filings

📖 Plain-language glossary — expand if you are new to this
P/E
How many times a year's net profit the price is worth (lower is cheaper relative to earnings). The P/E here is on trailing (last full-year) results; for companies whose earnings swing fast (memory chips and other cyclicals/high-growth), a forward P/E on this year's expected earnings is more accurate.
P/B
Price relative to net assets (equity). Around 1x means it trades near book value; below 1x means below book.
P/S
Price relative to a year's revenue — useful for growth companies with thin earnings.
Net debt / EV
Net debt = interest-bearing debt − cash. Negative means more cash than debt (net cash). EV (enterprise value) = market cap + net debt, closer to what it would cost to buy the whole business.
EV/EBIT · EV/EBITDA · EV/Sales
Enterprise value against operating profit (EBIT), EBITDA, or revenue. Unlike P/E these reflect debt and cash; lower is cheaper relative to earnings power or sales.
FCF / FCF yield
Free cash flow = operating cash − capex, the cash actually left over. FCF yield = FCF ÷ market cap; higher means more cash generated per unit of market value.
Intrinsic value (DCF)
Future free cash flow (or, for some capex-heavy but profitable names, forecast earnings) discounted to today to estimate per-share value. Because it shifts a lot with the discount-rate and growth assumptions, it is shown as a bear/base/bull range, and the basis and assumptions are disclosed in one line beneath it.
ROE
How much profit the company earns in a year on its equity (%). Higher means better returns on capital.
EPS / BPS
Earnings per share / net assets (book value) per share.
Operating / net margin
Profit left from the core business / final profit after tax and interest, per unit of revenue.
Debt ratio
Debt relative to equity (%). Higher means more reliance on borrowing (norms vary by sector).
Current ratio
Assets convertible to cash within a year against debt due within a year. Above 100% leaves some short-term headroom.
Interest coverage
How many times operating profit covers the interest owed. Below 1x means operating profit alone struggles to cover interest.
Dividend yield / payout ratio
The year's dividend as a % of today's price / the share of earnings paid out as dividends.
Revenue CAGR
Multi-year growth expressed as a single yearly average (compound annual growth rate).
RSI (short-term signal)
Whether recent price action is overheated or beaten down. Above 70 is overbought, below 30 oversold.
MA20 / MA60 (moving averages)
The 20- and 60-day average price. Price above them signals a firmer short-term trend.
vs 52-week high
How far below the past year's peak the price sits now (%).

All figures are for reference only; how they read varies by sector and over time.

Sources: Korea FSC market-price API (data.go.kr), OpenDART, KRX/KIND — public data only.

Bong Stocks presents public-data-based information for reference only. It is not investment advice and contains no target prices, ratings, or buy/sell recommendations. Verify independently before making any decision.